[go: up one dir, main page]

Maternal resveratrol treatment during pregnancy improves adverse fetal outcomes in a rat model of severe hypoxia

Placenta. 2012 May;33(5):449-52. doi: 10.1016/j.placenta.2012.01.012. Epub 2012 Feb 10.

Abstract

Prenatal hypoxia is a common complication in pregnancy. We sought to determine whether resveratrol, a phytoalexin shown to improve health in several species, improves fetal outcomes associated with prenatal hypoxia in rats. Supplementation of maternal diets with resveratrol (4 g/kg diet) from gestational day (GD) 7 to GD21 almost completely reversed fetal demise in hypoxic (8.5% oxygen) pregnancies. We also show that resveratrol crosses the placenta, and may affect the fetus directly.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antioxidants / therapeutic use*
  • Drug Evaluation, Preclinical
  • Female
  • Fetal Hypoxia / drug therapy*
  • Pregnancy
  • Pregnancy Outcome
  • Rats
  • Resveratrol
  • Stilbenes / therapeutic use*

Substances

  • Antioxidants
  • Stilbenes
  • Resveratrol